Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...

Bioavailability: Overview

Bioavailability: Overview

Bioavailability refers to the proportion of an unaltered drug that, after administration, enters the systemic circulation and can be distributed to the desired action site. Factors such as gastrointestinal (GI) absorption and liver biotransformation influence the bioavailability of a drug when it is administered orally. When a drug is administered intravenously, it enters the systemic circulation directly; by definition, its bioavailability is assumed to be 100%. The bioavailability of an...

Biopharmaceutics and Pharmacokinetics: Overview

Biopharmaceutics and Pharmacokinetics: Overview

Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Determining the individualized probability of myocardial recovery: The multicenter RecoverHeart calculator.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2026

Same author

Cell-Free DNA Profiles End-Organ Injury and Predicts Outcomes in Advanced Heart Failure With Left Ventricular Assist Device Implantation.

Circulation. Heart failure·2025

Same author

A Discovery of Potentially Hereditary Cardiac Angiosarcoma.

JACC. Case reports·2025

Same author

Impact of standardized team-based care on cardiogenic shock outcomes over time.

ESC heart failure·2025

Same author

Step towards device transparency and reporting for better outcomes in heart transplantation using ex-vivo machine perfusion.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2025

Same author

Impact of Cooling Strategies on Transfusion Requirements in Aortic Hemiarch Surgery.

Aorta (Stamford, Conn.)·2025

Search research articles

Related Experiment Video

Updated: Nov 17, 2025

Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula

Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula

Published on: January 26, 2024

New development and update on China Bioanalysis Forum.

Fan Jin¹, Daniel Tang², Kelly Dong³

¹Bioanalytical Chemistry, Covance Pharmaceutical R&D (Shanghai) Co. Ltd Pudong, Shanghai 201203, PR China.

|February 12, 2021

Summary

The China Bioanalysis Forum (CBF) is now part of the Chinese Pharmaceutical Association (CPA), enhancing bioanalytical support for drug development in China. This collaboration fosters advancements in innovative medicines and Traditional Chinese Medicine research.

Keywords:

CBF China Bioanalysis Forum China Bioanalytical regulation Chinese Pharmaceutical Association

More Related Videos

Author Spotlight: Exploring Sex-Specific Glial Signatures and Therapeutic Leads for Alzheimer's Disease

Author Spotlight: Exploring Sex-Specific Glial Signatures and Therapeutic Leads for Alzheimer's Disease

Published on: May 20, 2024

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

Related Experiment Videos

Last Updated: Nov 17, 2025

Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula

Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula

Published on: January 26, 2024

Author Spotlight: Exploring Sex-Specific Glial Signatures and Therapeutic Leads for Alzheimer's Disease

Author Spotlight: Exploring Sex-Specific Glial Signatures and Therapeutic Leads for Alzheimer's Disease

Published on: May 20, 2024

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

Area of Science:

Pharmacology and Pharmaceutical Sciences
Analytical Chemistry
Biotechnology

Background:

The China Bioanalysis Forum (CBF) joined the Chinese Pharmaceutical Association (CPA) in late 2019.
An inaugural ceremony and scientific symposium were held in Shanghai on September 18, 2020, with key stakeholders from industry, CROs, hospitals, and academia.

Discussion:

Presentations covered critical areas such as Drug Metabolism and Pharmacokinetics (DMPK) and bioanalytical support for drug discovery and development.
Expert discussions also included valuable insights from Traditional Chinese Medicine research.

Key Insights:

Bioanalysis is crucial for the development of innovative and generic drugs in China.
The integration of CBF into CPA signifies a strengthened network for bioanalytical sciences.

Outlook:

Continued growth in China's R&D sector will be supported by advancements in bioanalytical methodologies.
The collaboration is expected to drive innovation in pharmaceutical research and development within the region.